HealthQuill liver cancer
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Drugs Health Pharma

GenX faces a higher risk of 17 cancer types than older generation

Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.

Read More
US regulator, the FDA has approved Gilead Sciences, Inc.'s supplemental new drug application for treating chronic hepatitis B virus in paediatric patients six years of age and older.
Drugs Health Pharma

FDA nod for Gilead to expand hepatitis drug to six years or older patients

HQ Team March 28, 2024: US regulator, the FDA has approved Gilead Sciences, Inc.’s supplemental new drug application for treating chronic hepatitis B.

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Drugs Health Pharma

Bristol Myers says liver cancer therapy trial improves overall survival rate

HQ Team March 20, 2024: Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival.

Read More
Rocheā€™s atezolizumab drug Tecentriq, to treat cancer, was approved by Britainā€™s Medicines and Healthcare Products Regulatory Agency.
Drugs Health Pharma

Rocheā€™s under-the-skin cancer injection gets Britainā€™s nodĀ 

HQ Team August 30, 2023: Rocheā€™s atezolizumab drug Tecentriq, to treat cancer, was approved by Britainā€™s Medicines and Healthcare Products Regulatory Agency. Tecentriq.

Read More
Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients with metastatic uveal melanoma, giving the Delaware-based firm $60 million fund access.
Drugs Health Pharma

Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma

HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.

Read More
The Hepatitis C virus wears a ā€œmaskā€ and remains hidden to evade the human immune system to cause inflammation and scarring of the liver, Dutch researchers found.
Drugs Health Pharma

Hepatitis C virus uses a molecular mask to escape immune systems: Dutch research

HQ Team July 6, 2023: The Hepatitis C virus wears a ā€œmaskā€ and remains hidden to evade the human immune system to cause.

Read More
liver cancer
Health Uncategorized

Liver cancer deaths may increase by 55% in another 20 years

Liver cancer deaths set to increase by 50 percent by 2040; study

Read More